Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2020 Filed Jul 13, 2020 21:51 UTC |
Mahmood NadirChief Business Officer
|
GrantStock Option (right to buy) · Derivative | 48,400 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019038 · doc4.xml · derivative · entry 1 Mahmood Nadir · CIK 0001816598 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,400 Underlying: Common Stock · 48,400 shares Expires 2030-07-08 F1 · derivative.exercise_date: This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 21:56 UTC |
Trager JamesChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 31,100 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019049 · doc4.xml · derivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,100 Underlying: Common Stock · 31,100 shares Expires 2030-06-30 F2 · derivative.exercise_date: This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 21:56 UTC |
Trager JamesChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 82,400 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019049 · doc4.xml · derivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,400 Underlying: Common Stock · 82,400 shares Expires 2030-07-08 F1 · derivative.exercise_date: This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 14, 2020 01:49 UTC |
Scheiner ZacharyDirector
|
GrantStock Option (right to buy) · Derivative | 10,700 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019035 · doc4.xml · derivative · entry 1 Scheiner Zachary · CIK 0001816523 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,700 Underlying: Common Stock · 10,700 shares Expires 2030-07-08 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first anniversary of July 9, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). F2 · ownership.nature: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund, L.P. (the "Nexus Fund") and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option, which will offset advisory fees owed by the Fund, the Nexus Fund and the Account to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 21:46 UTC |
Rajangam KanyaChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 70,600 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019030 · doc4.xml · derivative · entry 1 Rajangam Kanya · CIK 0001816676 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,600 Underlying: Common Stock · 70,600 shares Expires 2030-07-08 F1 · derivative.exercise_date: This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 14, 2020 01:42 UTC |
PATTERSON LEONE DDirector
|
GrantStock Option (right to buy) · Derivative | 18,300 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019026 · doc4.xml · derivative · entry 2 PATTERSON LEONE D · CIK 0001233539 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Underlying: Common Stock · 18,300 shares Expires 2030-07-08 F2 · derivative.exercise_date: All shares subject to the option vest 100% on the first anniversary of July 1, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 14, 2020 01:42 UTC |
PATTERSON LEONE DDirector
|
GrantStock Option (right to buy) · Derivative | 10,700 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019026 · doc4.xml · derivative · entry 1 PATTERSON LEONE D · CIK 0001233539 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 Underlying: Common Stock · 10,700 shares Expires 2030-07-08 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first anniversary of July 9, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 14, 2020 01:40 UTC |
HASTINGS PAUL JDirector · See Remarks
|
GrantStock Option (right to buy) · Derivative | 202,400 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019024 · doc4.xml · derivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,400 Underlying: Common Stock · 202,400 shares Expires 2030-07-08 F1 · derivative.exercise_date: This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 14, 2020 01:45 UTC |
Shawver LauraDirector
|
GrantStock Option (right to buy) · Derivative | 18,300 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019029 · doc4.xml · derivative · entry 2 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Underlying: Common Stock · 18,300 shares Expires 2030-07-08 F2 · derivative.exercise_date: All shares subject to the option vest 100% on the first anniversary of July 1, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a "change in control" of the Issuer occur (as defined in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as defined in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 14, 2020 01:45 UTC |
Shawver LauraDirector
|
GrantStock Option (right to buy) · Derivative | 10,700 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019029 · doc4.xml · derivative · entry 1 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 Underlying: Common Stock · 10,700 shares Expires 2030-07-08 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first anniversary of July 9, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 21:56 UTC |
Plunkett MatthewChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 77,800 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019047 · doc4.xml · derivative · entry 1 Plunkett Matthew · CIK 0001557551 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,800 Underlying: Common Stock · 77,800 shares Expires 2030-07-08 F1 · derivative.exercise_date: This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 14, 2020 01:57 UTC |
George SimeonDirector
|
GrantStock Option (right to buy) · Derivative | 10,700 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019051 · doc4.xml · derivative · entry 1 George Simeon · CIK 0001595117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 Underlying: Common Stock · 10,700 shares Expires 2030-07-08 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first anniversary of July 9, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 14, 2020 01:50 UTC |
Dybbs MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 10,700 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019037 · doc4.xml · derivative · entry 1 Dybbs Michael · CIK 0001601264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 Underlying: Common Stock · 10,700 shares Expires 2030-07-08 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first anniversary of July 9, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 14, 2020 01:47 UTC |
Behbahani AliDirector
|
GrantStock Option (right to buy) · Derivative | 10,700 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-042331 · doc4.xml · derivative · entry 1 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 Underlying: Common Stock · 10,700 shares Expires 2030-07-08 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first anniversary of July 9, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.